Anagenex

Anagenex is a seed-stage biotechnology company focused on challenging targets, building a novel platform for drug discovery. The company combines machine learning with highly parallel biochemical tools, such as DNA-Encoded Libraries (DELs) and Affinity Selection Mass Spectrometry (ASMS), to analyze more compounds more efficiently than ever before. By utilizing large datasets throughout the search process and allowing machine learning models to guide experiments, Anagenex can identify molecules for the most difficult problems in drug discovery, bringing first-in-class treatments to patients.